Melanosis Clinical Trial
Official title:
A Pilot Study Comparing the Efficacy of 1064 Q-switch Laser vs. Glycolic Acid Peels for the Treatment of Melasma: A Randomized Control Trial
The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.
Participants in this study will be patients at the dermatology clinic who are clinically diagnosed with at least a 2X2 cm patch of melasma on each side of their face (forehead or cheek). Starting at 2 weeks before treatment (week 2), both sides will be pretreated and primed with 4% hydroquinone with, if necessary, 2.5% hydrocortisone cream BID. On the treatment day (2-weeks) and 6-weeks one half of the subject's face will receive glycolic acid peels and the other half of the face will receive 1064nm Q-switch laser. This study is a pilot study designed to determine feasibility of these procedures. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05119413 -
Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma
|
Phase 2 | |
| Terminated |
NCT00863278 -
Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser
|
Phase 4 | |
| Recruiting |
NCT00927771 -
Azelaic Acid Versus Hydroquinone in Melasma
|
Phase 4 | |
| Not yet recruiting |
NCT05930366 -
Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation
|
N/A | |
| Not yet recruiting |
NCT05930392 -
Comparative Evaluation of Microsurgery vs Conventional Surgical Technique of Gingival Depigmentation
|
N/A | |
| Active, not recruiting |
NCT01976286 -
A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma
|
N/A | |
| Not yet recruiting |
NCT03585179 -
Oral and Topical Tranexamic Acid for the Treatment of Melasma
|
Phase 3 |